机译:偏头痛的未来:不仅仅是另一种药
Dr Cady is a consultant for Aradigm, GlaxoSmithKline, Jazz Pharmaceuticals, Merck & Co, and Ortho-McNeil Neurologies, on the advisory board for Allergan, Atrlx Laboratories, Capnla, Endo Pharmaceuticals, GlaxoSmithKline, MAP Pharmaceuticals, MedPointe, Merck & Co, Ortho-McNeil Neurologies, and Zogenix, and receives research grant support from Advanced Bionics, Allergan, Alexa, BioAlliance Pharma, Capnla, GlaxoSmithKline, Jazz Pharmaceuticals, Merck & Co, Neuralieve, Ortho-McNeil Neurologies, and Quality Metrics.Address correspondence to Roger K. Cady, MD, Banyan Group, Ine, Headache Care Center, 3805 S Kansas Expressway, Springfield, MO 65807 (ready @head achecare.com).© 2009 Mayo Foundation for Medical Education and ResearchRoger K. Cady, MDHeadache Care CenterSpringfield, MO,;
机译:Tibetan Medicine Ru-yi-Zhen-Bao丸通过介导PAG抗伤害性通道表现出抗偏头痛效果
机译:偏头痛管理:超越药丸
机译:偏头痛管理:超越丸
机译:将肽组织引入偏头痛研究:偏头痛和阿片类药物诱导患有液相色谱质谱法的神经肽和阿片类药物研究
机译:口服避孕药:药物网站上对药丸的描述分析。
机译:偏头痛的未来:不仅仅是另一种药
机译:偏头痛的未来:不仅仅是另一种药
机译:缓解偏头痛的压力:偏头痛预防对国防部未来医疗服务消费的影响